Activity Description:

The Grand Rounds presentation hopes to educate all healthcare professionals about the current recommended guidelines for treatment of Hypertension in the outpatient setting. We will discuss the International Society of Hypertension Global Hypertension Practice Guidelines and an overall approach to Hypertension treatment with the most recent recommendations. This includes proper diagnostics and techniques for quantifying patients' blood pressure, as well as a variety of medications used for treatment. This presentation will allow healthcare professionals to further understand Hypertension treatment in the adult population.

Target Audience: 

Anesthesiology, Diagnostic Radiology, Gastroenterologist, Internal Medicine, Medical Genetics, Pathology, Primary Care, Physical Medicine & Rehabilitation, Surgery, Urology

Learning Objectives:

1. Familiarize with the ISH Hypertension treatment guidelines

2. Understand the techniques used in the measurement of blood pressure

3. Learn a variety of medications and treatment options for hypertension

4. Apply these guidelines to the adult population with several patient cases

 Moderator:

Bhavesh Shukla, MD

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose.